Kraig Biocraft Laboratories, Inc. declares a significant achievement today, marking the completion of rearing the first generation of its innovative BAM-1 parental strains in its spring production trial.
Supervised by renowned sericulture expert Nirmal Kumar, the company surpassed all anticipated rates and control benchmarks, yielding exceptional cocoon production.
Kumar commended the robustness of the BAM-1 parental lines, noting their rapid growth and impeccable health. With the successful rearing stage now concluded, Kraig Labs prepares to scale up production based on the performance and resilience of the BAM-1 parental lines.
The meticulously monitored trial revealed no instances of disease across the four production batches, affirming the strength of the recombinant spider silk strains.
CEO Kim Thompson expressed gratitude to the team, consultants, and Kumar for surpassing expectations, citing faster growth rates and larger cocoon sizes compared to previous R&D outcomes.
As the current trial approaches completion, ongoing data collection indicates a high success rate, positioning the company to accelerate production to metric-ton levels.
Thompson anticipates the conclusion of the trial to confirm the two-year acclimation program's success, signaling a promising future for Kraig Biocraft Laboratories in the silk production landscape.
